New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer. Latest News Multiple Trials Underway to Create a Breast Cancer Vaccine Deseret News News | May 2023 Veterans More Likely to Get Genetic Testing with In-Person Consults Genome Web News | May 2023 Eradicate Breast Cancer? The Hunt for a Vaccine Looks Promising Bloomberg News | May 2023 What You Should Know About Genetic Testing and How it Can Save Lives Penn Live News | May 2023 Genetic Sequencing May Identify Cancers Often Missed by Traditional Screening Guidelines The ASCO Post News | May 2023 Prostate Cancer Foundation-Funded Study Sheds Light on Improving Access to Precision Oncology Care for U.S. Veterans with Prostate Cancer Prostate Cancer Foundation News | May 2023 Folding@home: How You, and Your Computer, Can Play Scientist Penn Medicine News News | May 2023 Six Warning Signs of Ovarian Cancer Daily Mail News | May 2023 New Hope for Breast Cancer Survivors: Study Finds a Break in Hormone Suppression Therapy to Bear Children Is Relatively Safe Boston Globe News | May 2023 BRCA Mutations in Men: Three Things to Know Penn Medicine News News | May 2023 AACR Annual Meeting Highlights Showcased in Final Plenary Session American Association for Cancer Research News | April 2023 Next-Generation Cancer Therapies Will Reshape Cancer Treatment in the Coming Years American Association for Cancer Research News | April 2023 Broadening Cancer Screening with Whole-Exome Sequencing Cancer Discovery News | April 2023 Making What’s Next in Medicine: Why Research at Penn Powers Many FDA-Approved Treatments Penn Medicine News News | April 2023 AACR Annual Meeting 2023 Overview: Advancing the Frontiers of Cancer Science and Medicine American Association of Cancer Research News | April 2023 Breakthroughs, Practice-Changing Data Expected at AACR 2023 Oncology Business Review News | April 2023 Penn Medicine at the AACR Annual Meeting 2023 Penn Medicine News News | April 2023 Abramson Cancer Center Leader Outlines Immunotherapy Advances AACR Journals: Cancer Discovery News | April 2023 Pagination First page« First Previous page‹‹ … Page2 Page3 Page4 Page5 Current page6 Page7 Page8 Page9 Page10 … Next page›› Last pageLast »
New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer.
Genetic Sequencing May Identify Cancers Often Missed by Traditional Screening Guidelines The ASCO Post News | May 2023
Prostate Cancer Foundation-Funded Study Sheds Light on Improving Access to Precision Oncology Care for U.S. Veterans with Prostate Cancer Prostate Cancer Foundation News | May 2023
New Hope for Breast Cancer Survivors: Study Finds a Break in Hormone Suppression Therapy to Bear Children Is Relatively Safe Boston Globe News | May 2023
AACR Annual Meeting Highlights Showcased in Final Plenary Session American Association for Cancer Research News | April 2023
Next-Generation Cancer Therapies Will Reshape Cancer Treatment in the Coming Years American Association for Cancer Research News | April 2023
Making What’s Next in Medicine: Why Research at Penn Powers Many FDA-Approved Treatments Penn Medicine News News | April 2023
AACR Annual Meeting 2023 Overview: Advancing the Frontiers of Cancer Science and Medicine American Association of Cancer Research News | April 2023
Breakthroughs, Practice-Changing Data Expected at AACR 2023 Oncology Business Review News | April 2023
Abramson Cancer Center Leader Outlines Immunotherapy Advances AACR Journals: Cancer Discovery News | April 2023
